Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-10-30
2010-11-16
Navarro, Mark (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
07833717
ABSTRACT:
The identification of a highly conserved, immunologically accessible antigen at the surface ofNeisseriafacilitates treatment, prophylaxis, and diagnosis ofNeisseriadiseases. This antigen is highly resistant to Proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from threeNeisseria meningitidisstrains and from oneNeisseria gonorrhoeaestrain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of theNeisseriasurface protein, and antibodies that bind to this protein are also disclosed.
REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
patent: 5106726 (1992-04-01), Wang
patent: 5834591 (1998-11-01), Normark et al.
patent: 6063386 (2000-05-01), Dale et al.
patent: 6287574 (2001-09-01), Brodeur et al.
patent: 6419932 (2002-07-01), Dale
patent: 6716433 (2004-04-01), Dale
patent: 7273611 (2007-09-01), Brodeur et al.
patent: 2003/0202980 (2003-10-01), Caplan et al.
patent: 2007/0110766 (2007-05-01), Brodeur et al.
patent: 2008/0107674 (2008-05-01), Brodeur et al.
patent: 2008/0107676 (2008-05-01), Brodeur et al.
patent: 2008/0124337 (2008-05-01), Brodeur et al.
patent: 2008/0124351 (2008-05-01), Brodeur et al.
patent: 2008/0124353 (2008-05-01), Brodeur et al.
patent: 0273116 (1988-07-01), None
patent: 0474313 (1992-03-01), None
patent: 0301992 (1995-05-01), None
patent: 0474313 (1997-04-01), None
patent: 94/05703 (1994-03-01), None
Aho et al., “A comparative analysis of pilin genes from pathogenic and nonpathogenicNeisseriaspecies,”Microbial Pathogenesis28:81-88, 2000.
Bastian et al., “Antiserum to scrapie-associated fibril protein cross-reacts withSpiroplasma minimfibril proteins,”Journal of Clinical Microbiology25(12):2430-2431, 1987.
Brodeur et al., “Protection against infection withNeisseria meningitidisGroup B serotype 2b by passive immunization with serotype-specific monoclonal antibody,”Infection and Immunity50(2):510-516, 1985.
Brodeur et al., “Mouse models of infection forNeisseria meningitidisB,2b andHaemophilus influenzaetype b diseases,”Can. Journal Microbiology32:33-37, 1986.
Butler et al., “Identification and characterization of proteinase K-resistant proteins in members of the class mollicutes,”Infection and Immunity59(3):1037-1042, 1991.
Bernardini et al., “Proteome analysis ofNeisseria meningitidisserogroup A,”Proteomics4:2893-2926, 2004.
Bhat et al., “The opacity proteins ofNeisseria gonorrhoeaestrain MS11 are encoded by a family of 11 complete genes,”Molecular Microbiology6(8):1073-1076, 1992.
Bhat et al., “The opacity proteins ofNeisseria gonorrhoeaestrain MS11 are encoded by a family of 11 complete genes,”Molecular Microbiology5(8):1889-1901, 1991.
Bhattacharjee et al., “Purification and characterization of H.8 antigen from Group BNeisseria meningitidis,” Infection and Immunity56(4):773-778, 1988.
Bjune et al., “Effect of outer membrane vesicle vaccine against Group B meningococcal disease in Norway,”The Lancet338(8775):1093-1096, 1991.
Cannon et al., “Monoclonal Antibody that Recognizes an Outer Membrane Antigen Common to the PathogenicNeisseriaSpecies but not to Most NonpathogenicNeisseriaSpecies,”Infection and Immunity43(3):994-999 (1984).
Costa et al., “Meningococcal Disease in Sao Paulo, Brazil,”NIPH Annals14(2):215-218, Dec. 1991.
Drocourt et al., “Nucleotide sequence of the xylose isomerase gene fromStreptomyces violaceoniger,” Nucleic Acids Research16(19):9337, 1988.
Frasch et al., “Development and Evaluation of Group B Serotype 2 Protein Vaccines: Report of a Group B Field Trial,”Medecine Tropicale43(2):117-180, 1983.
Frasch et al., “Immune responses of adults and children to group BNeisseria meningitidisouter membrane protein vaccines,”in Bacterial Vaccines, 262-272, 1987.
Frasch et al., “Outer membrane proteins ofNeisseria meningitidis: Structure and importance in meningococcal disease,”Clinical and Investigative Medicine9(2):101-107, 1986.
Frasch et al., “Serotype antigens ofNeisseria meningitidisand a proposed scheme for designation of serotypes,”Review of Infectious Diseases7(4):504-410, 1985.
Frasch et al., “Status of a Group BNeisseria meningitidisvaccine,”Eur. Journal of Clinical Microbiology4(6):533-536, 1985.
Frasch et al., “Antibody response of adults to an aluminum hydroxide-adsorbedNeisseria meningitidisserotype 2b protein-Group B. polysaccharide vaccine,”The Journal of Infectious Diseases158(4):710-718, 1988.
Frasch et al., “Vaccines for prevention of meningococcal disease,”Clinical Microbiology Review2:S134-S138, 1989.
Goldschneider et al., “Human Immunity to the Meningococcus: The Role of Humoral Antibodies,”Journal of Experimental Medicine129:1307-1326, 1969.
Goldschneider et al., “Human Immunity to the Meningococcus: Development of Natural Immunity,”Journal of Experimental Medicine129:1327-1348, 1969.
Gotschlich et al., “Human immunity to the meningococcus,”The Journal of Experimental Medicine129(6):1349-1365, 1969.
Guttormsen et al., “Humoral immune response to Class 1 outer membrane protein during the course of meningococcal disease,”Infection and Immunity62(4):1437-1443, 1994.
Kupsch et al., “Variable opacity (opa) outer membrane proteins account for the cell tropisms displayed byNeisseria gonorrhoeaefor human leukocytes and epithelial cells,”The EMBO Journal12(2):641-650, 1993.
Lathe, “Synthetic oligonucleotide probes deduced from amino acid sequence data: Theoretical and practical considerations,”Journal of Molecular Biology 183:1-12, 1985.
Lussier et al., “Detection ofNeisseria gonorrhoeaeby dot-enzyme immunoassay using monoclonal antibodies,”Journal of Immunoassay10(4):373-394, 1989.
Mandrell et al., “Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination,”Infection and Immunity57(5):1590-1598, 1989.
Martin et al., “Highly ConservedNeisseria meningitidisSurface Protein Confers Protection against Experimental Infection,”Journal of Experimental Medicine185(7): 1173-1183, 1997.
Martin et al., “Mapping of B-cell epitopes on the outer membrane P2 porin protein ofHaemophilus influenzaeby using recombinant proteins and synthetic peptides,”Infection and Immunity59(4):1457-1464, 1991.
Martin et al., “Immunological characterization of the lipooliogosaccharide B band ofBordetella pertussis,” Infection and Immunity60(7):2718-2775, 1992.
Moreno et al., “Immunity and protection of mice againstNeisseria meningitidisGroup B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide,”Infection and Immunity47(2):527-533, 1985.
Munkley et al., “Blocking of bactericidal killing ofNeisseria meningitidisby antibodies directed against Class 4 outer membrane protein,”Microbial Pathogenesis11:447-452, 1991.
Nicholson et al., “Outer membrane proteins of three pathogenic leptospira species,”Veterinary Microbiology36:123-138, 1993.
Onodera et al., “Isolation of scrapie agent from the placenta of sheep with natural scrapie in Japan,”Microbiology and Immunology37(4):311-316, 1993.
Poolman et al., “Immunogenicity of meningococcal antigens as detected in patient sera,”Infection and Immunity40:398-406, 1983.
Prusiner et al., “Attempts to restore scrapie prion infectivity after exposure to protein denaturants,”Proceedings of the National Academy of Sciences of the USA90:2793-2797, 1993.
Reingold et al., “Age-specific differences in duration of clinical protection after vaccination with meningococcal pol
Brodeur Bernard R.
Hamel Josee
Martin Denis
Rioux Clement
ID Biomedical Corporation
Navarro Mark
Seed IP Law Group PLLC
LandOfFree
Proteinase K resistant surface protein of Neisseria... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteinase K resistant surface protein of Neisseria..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteinase K resistant surface protein of Neisseria... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4240592